A-1 Ltd Q3 FY26: ₹69.81 Cr Sales, ₹0.96 Cr Profit, 3:1 Bonus, 10:1 Split & EV Dreams — But P/E at 454x?
1. At a Glance
₹24.4 stock. ₹1,121 crore market cap. Quarterly sales of ₹69.81 crore. Quarterly profit of ₹0.96 crore. Stock P/E of 454. Book value of ₹1.06. Price-to-book at 23.1x. ROE below 8%.
And yet — 132% one-year return.
Ladies and gentlemen, welcome to the chemistry lab of A-1 Ltd, where acids are cheap but valuations are explosive.
This is a wholesale chemical trading company with a side hustle in transportation… and now apparently an EV ambition through a subsidiary stake increase to 51%. In the latest quarter (December 2025), revenue fell 6.08% QoQ but profit jumped sharply from ₹0.07 crore in the previous quarter to ₹0.96 crore. That’s not growth. That’s CPR revival.
Oh — and management just approved a 3:1 bonus issue and a 10:1 stock split.
Low-margin business. Thin profits. High valuation. Corporate action fireworks.
Curious yet?
Good. Let’s open the beaker.
2. Introduction – When Chemical Trading Meets Market Chemistry
A-1 Ltd was incorporated in 2004. It buys acids and chemicals. It sells acids and chemicals. It transports acids and chemicals.
In FY23, 95% of revenue came from sale of goods. Transport receipts were 3%. Lifting income 2%.
So this isn’t a specialty chemical manufacturer with patents and secret formulas.
This is a trading house.
It procures nitric acid, sulphuric acid, hydrochloric acid, methanol, urea, and other industrial chemicals from suppliers like GNFC, GSFC, Hindalco, Nirma, SRF, Grasim and others — and supplies them to industrial clients.
Clientele includes BPCL, Reliance Industries, Vedanta, Amul, Meghmani, Munitions India and others.
Basically, if India needs acid — A-1 is somewhere in the middle.
But here’s the catch: trading businesses operate on razor-thin margins. Their superpower is volume, not margin.
And when your operating margin is 2.86% in the latest quarter… valuation at 454x earnings becomes a philosophical question.
Are we valuing the chemical trade?
Or the corporate actions?
Let’s investigate.
3. Business Model – WTF Do They Even Do?
Imagine a middleman who:
Buys nitric acid in bulk
Stores it
Transports it
Delivers it to factories
Earns 2–3% margin
That’s A-1 Ltd.
Product list includes:
Nitric Acid
Sulphuric Acid
Hydrochloric Acid
Methanol
Ethyl Acetate
Urea
Nitro Benzene
Poly Aluminium Chloride
Formaldehyde
They also export HCL, HNO3, sulphuric acid, calcium chloride and glycerin.
So yes — it’s a chemicals supermarket for industrial India.
On the logistics side, they operate tankers for pan-India transportation.
Now here’s where it gets spicy:
In November 2025, they proposed:
3:1 bonus issue
10:1 stock split
Increase subsidiary stake in A-1 Sureja Industries from 45% to 51%
And A-1 Sureja received orders for 1,425 low-speed EVs.
Wait.
Chemical trader → EV association.
This is not diversification. This is Bollywood plot twist.
Is this a margin expansion strategy or valuation expansion strategy?
